Eucrisa 20 mg/g
crisaborole · OINTMENT · Pfizer Laboratories Div Pfizer Inc
Eucrisa is a prescription ointment applied directly to the skin to treat mild to moderate atopic dermatitis (eczema) by reducing inflammation. It contains crisaborole, a phosphodiesterase 4 inhibitor that works by blocking inflammatory signals in the skin.
Key Facts
- Brand Name
- Eucrisa
- Generic Name
- crisaborole
- NDC Code (Product)
55724-211- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 20 mg/g
- Dosage Form
- OINTMENT
- Route
- TOPICAL
- Marketing Status
- Application #
- NDA207695
- Drug Class
- Phosphodiesterase 4 Inhibitor [EPC]
- Marketing Start
- 01/30/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Eucrisa used for?
Eucrisa is a prescription ointment applied directly to the skin to treat mild to moderate atopic dermatitis (eczema) by reducing inflammation. It contains crisaborole, a phosphodiesterase 4 inhibitor that works by blocking inflammatory signals in the skin.
Is Eucrisa a controlled substance?
Eucrisa is not classified as a controlled substance by the DEA.
What is the generic name for Eucrisa?
The generic name for Eucrisa is crisaborole. There are no other listed brand versions of crisaborole.
What is the NDC code for Eucrisa 20 mg/g?
The NDC (National Drug Code) for Eucrisa 20 mg/g is 55724-211, listed by Pfizer Laboratories Div Pfizer Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)